Frozen plasma, buffy coat, FFPE blocks and slides
Research

Reference Medicine shares their new breast cancer research at ECP 2024

Sep 9, 2024

Medical Director, Zoran Gatalica, MD, presents new findings on TIL and HER2-low expression in relation to MammaPrint and BluePrint risk status.

Originally presented at the 36th European Congress of Pathology in Florence, Italy.

Download

Subscribe for updates

No spam — just the news you want: product launches, process improvements, and discounts on our already great pricing.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Media Contact

For more information or to schedule an interview, please contact:
Jen Ringler
ReadHealthy Communications
[email protected]

Share this post

More research
Research
Jun 12, 2024

Nike Bahlmann, Director of Global Support at BioEcho Life Sciences, presents at EACR 2024

Read article
Research
Jun 2, 2024

Improving RNA Extraction from FFPE tissues for RNA Sequencing Applications

Read article
Research
Mar 11, 2024

New research on TILs and HER2 status in apocrine breast cancer published in Biomolecules and Biomedicine

Read article
See all
Process
Products
Pricing
Inventory

Subscribe to our newsletter

No spam — just the news you want: product launches, process improvements, and discounts on our already great pricing.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
 | 
© 2024 Reference Medicine. All rights reserved